In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
| 10-K | 10-K | 10-K | 10-K/A | 10-K/A |
Revenues | 0.0 | 0.0 | 0.0 | -0.1 | -0.1 |
Revenue growth | | | -100.0% | 11.8% | |
Cost of goods sold | 0.0 | 0.0 | 0.0 | -1.5 | -1.3 |
Gross profit | 0.0 | 0.0 | 0.0 | 1.3 | 1.1 |
Gross margin | | | | -956.4% | -931.7% |
Selling, general and administrative [+] | 0.2 | 0.9 | 0.1 | 0.6 | 0.4 |
General and administrative | 0.2 | 0.9 | | 0.6 | 0.4 |
Research and development | | 0.0 | 0.0 | 0.2 | 0.1 |
Other operating expenses | | | | 1.3 | 1.3 |
EBITDA [+] | | -0.9 | -0.2 | -0.7 | -0.6 |
EBITDA growth | -81.6% | 411.6% | -75.7% | 14.3% | |
EBITDA margin | | | | 526.8% | 515.3% |
Depreciation and amortization | | 0.0 | 0.0 | 0.0 | 0.0 |
EBIT [+] | -0.2 | -0.9 | -0.2 | -0.7 | -0.6 |
EBIT growth | -81.7% | 408.8% | -75.4% | 14.5% | |
EBIT margin | | | | 528.2% | 515.8% |
Non-recurring items [+] | 0.0 | 0.0 | | | |
Asset impairment | 0.0 | 0.0 | | | |
Interest expense, net [+] | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 |
Interest expense | 0.0 | 0.0 | 0.1 | | |
Interest income | | | | 0.0 | 0.0 |
Other income (expense), net [+] | 0.3 | -0.3 | | -0.1 | -0.1 |
Gain (loss) on debt retirement | | -0.2 | | | |
Gain (loss) on derivative instruments | 0.3 | -0.1 | | | |
Other | 0.0 | -0.3 | -0.1 | -0.1 | -0.1 |
Pre-tax income | 0.2 | -1.3 | -0.2 | -0.9 | -0.8 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | 0.2 | -1.3 | -0.2 | -0.9 | -0.8 |
Net margin | | | | 628.1% | 615.1% |
|
Basic EPS [+] | $0.00 | ($0.04) | ($0.02) | ($0.07) | ($0.06) |
Growth | -110.6% | 102.3% | -73.4% | 7.1% | |
Diluted EPS [+] | $0.00 | ($0.03) | ($0.02) | ($0.07) | ($0.06) |
Growth | -104.5% | 72.6% | -76.5% | 7.1% | |
|
Shares outstanding (basic) [+] | 39.5 | 34.5 | 12.8 | 12.8 | 12.0 |
Growth | 14.4% | 170.5% | 0.0% | 6.7% | |
Shares outstanding (diluted) [+] | 125.1 | 45.9 | 14.5 | 12.8 | 12.0 |
Growth | 172.9% | 217.1% | 13.4% | 6.7% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |